hrp0098p3-46 | Bone, Growth Plate and Mineral Metabolism | ESPE2024

Parathyroid adenoma in a 12-year-old boy with incidental hypercalcemia

Koga Nobuhiko , Yatsuga Shuichi , Kojima Kanako , Sasaki Fusako , Nagamitsu Shinichiro

Background: Hypercalcemia, with hyperparathyroidism in children, is a very rare disease. The symptoms of hypercalcemia in children present with hypotonia, poor feeding, vomiting, constipation, abdominal pain, lethargy, polyuria, dehydration, failure to thrive, and seizures. Hyperparathyroidism in children is induced from genetically malignant or benign parathyroid adenoma.Case: The case is a 12-year-old boy who had no si...

hrp0095p2-40 | Bone, Growth Plate and Mineral Metabolism | ESPE2022

Overlooking hypoparatahyroidism in an 11-year-old boy patient with CHARGE syndrome

Sasaki Fusako , Kojima Kanako , Sasaoka Daiki , Koga Nobuhiko , Yatsuga Shuichi , Nagamitsu Shinichiro

Introduction: CHARGE syndrome is characterized with coloboma, heart defects, atresia of choanae, retardation of growth and development, genital hypoplasia and ear abnomalities. Recently, symptoms of CHARGE syndrome and 22q11.2 deletion syndrome were known to overlap. We describe a case of CHARGE syndrome that has variation in the CHD7 gene with hypoparathyroidism.Case Report: The patient is an 11-year-old boy who was bor...

hrp0095p2-73 | Diabetes and Insulin | ESPE2022

Recurrent glycogenic hepatopathy in an 11-year-old boy with poor glycemic controlled type 1 diabetes mellitus

Sasaoka Daiki , Kojima Kanako , Koga Nobuhiko , Sasaki Fusako , Tanaka Yukari , Yatsuga Shuichi , Nagamitsu Shinichiro

Introduction: Glycogenic hepatopathy (GH) is a rare diabetic complication that induces hepatomegaly and elevated transaminases, which can often appear in type 1 diabetes mellitus (T1DM) with poor glycemic control. GH appears when excess glycogen accumulates in the liver through continued hyperglycemia with intensive insulin therapy. We show a pediatric case of recurrent GH due to poor glucose controlled with complicated family environment and mildly intellectu...

hrp0095p2-155 | GH and IGFs | ESPE2022

Poor efficacy of growth hormone treatment in a patient with fetal alcohol syndrome

Koga Nobuhiko , Sasaoka Daiki , Tanaka Yukari , Sasaki Fusako , Yatsuga Shuichi , Nagamitsu Shinichiro Nagamitsu Shinichiro

Fetal alcohol syndrome (FAS) is established based on the presence or absence of characteristic facial features, prenatal/postnatal growth deficiency (height and/or weight < 10th percentile), deficient brain growth, neurobehavioral impairment, and maternal alcohol consumption during pregnancy. There have been no reports of growth hormone (GH) treatment in FAS; therefore, we report a case of GH treatment on FAS for small for gestational (SGA) short stature. The patient was a ...